Search research articles
Contact Us
Filters
Showing results (711-720 of 748) with videos related to
Page
of 75
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Jonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Genome Biology
|
April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Thaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Shuang G Zhao, William S Chen, Rajdeep Das, et al.
The Oncologist
|
June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains
Xiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Molecular Cancer Research : MCR
|
February 13, 2018
Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
Shirin Ilkhanizadeh, Hanna Sabelström, Yekaterina A Miroshnikova, et al.
Cell Reports
|
December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma
Christopher S Hackett, David A Quigley, Robyn A Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2021
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
D M Barrios, G S Phillips, A N Geisler, et al.
Cancer Research
|
January 14, 2026
A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader Molecules
Phillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules
Phillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Page
of 75
Search research articles
Search
Showing results (711-720 of 748) with videos related to
Sort By:
Page
of 75
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Jonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Genome Biology
|
April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Thaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
Shuang G Zhao, William S Chen, Rajdeep Das, et al.
The Oncologist
|
June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains
Xiaolin Zhu, Emily Chan, Michelle L Turski, et al.
Molecular Cancer Research : MCR
|
February 13, 2018
Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
Shirin Ilkhanizadeh, Hanna Sabelström, Yekaterina A Miroshnikova, et al.
Cell Reports
|
December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma
Christopher S Hackett, David A Quigley, Robyn A Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2021
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
D M Barrios, G S Phillips, A N Geisler, et al.
Cancer Research
|
January 14, 2026
A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader Molecules
Phillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules
Phillip Thienger, Irene Paassen, Xiaosai Yao, et al.
Page
of 75